Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
UBS Group
UBS
$167B
| $2.01M | ﹤0.01% |
113,660
+39,001
| +52% | +$741K |
|
2302
Innospec
IOSP
$2.36B
| $2.01M | ﹤0.01% |
29,238
-127,400
| -81% | -$8.86M |
|
2303
Republic Bancorp
RBCAA
$1.85B
| $2M | ﹤0.01% |
52,301
+2,834
| +6% | +$110K |
|
|
XELA
2304
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $2M | ﹤0.01% |
30
+24
| +400% | +$1.6M |
|
|
MODV
2305
DELISTED
ModivCare
MODV
| $2M | ﹤0.01% |
28,925
-22,600
| -44% | -$1.47M |
|
2306
MVB Financial
MVBF
$388M
| $1.99M | ﹤0.01% |
+100,851
| New | +$1.98M |
|
|
LTC
2307
LTC Properties
LTC
$2.18B
| $1.99M | ﹤0.01% |
52,404
-181,189
| -78% | -$7.13M |
|
|
CCI.PRA
2308
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $1.99M | ﹤0.01% |
1,779
| – | – |
|
2309
Coca-Cola Consolidated
COKE
$12.9B
| $1.99M | ﹤0.01% |
115,090
+102,620
| +823% | +$1.96M |
|
|
BUFF
2310
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $1.99M | ﹤0.01% |
49,879
+35,527
| +248% | +$1.28M |
|
|
IVTY
2311
DELISTED
Invuity, Inc
IVTY
| $1.98M | ﹤0.01% |
513,666
+95,550
| +23% | +$436K |
|
2312
Virtu Financial
VIRT
$5.8B
| $1.98M | ﹤0.01% |
59,859
-356,352
| -86% | -$9.22M |
|
2313
ePlus
PLUS
$2.25B
| $1.97M | ﹤0.01% |
50,756
+20,144
| +66% | +$776K |
|
|
EDN
2314
Edenor
EDN
$1.04B
| $1.97M | ﹤0.01% |
34,262
+10,999
| +47% | +$624K |
|
2315
CALL
Pilgrim's Pride
PPC
$7.45B
| $1.97M | ﹤0.01% |
+80,000
| New | +$2.15M |
|
|
VSLR
2316
DELISTED
VIVINT SOLAR, INC.
VSLR
| $1.97M | ﹤0.01% |
+539,395
| New | +$1.86M |
|
2317
Winnebago Industries
WGO
$871M
| $1.97M | ﹤0.01% |
52,274
-300,627
| -85% | -$13.9M |
|
2318
Exponent
EXPO
$3.34B
| $1.96M | ﹤0.01% |
49,804
-178,192
| -78% | -$6.74M |
|
|
ADMS
2319
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.96M | ﹤0.01% |
81,820
-575,263
| -88% | -$18.1M |
|
|
XLRN
2320
PUT
DELISTED
Acceleron Pharma
XLRN
| $1.96M | ﹤0.01% |
+50,000
| New | +$2.13M |
|
|
GRMN
2321
Garmin
GRMN
$55.7B
| $1.95M | ﹤0.01% |
33,104
-186,690
| -85% | -$11.4M |
|
2322
BRC Group Holdings
RILY
$285M
| $1.95M | ﹤0.01% |
100,000
| – | – |
|
2323
Aclaris Therapeutics
ACRS
$911M
| $1.94M | ﹤0.01% |
110,827
+99,029
| +839% | +$2.1M |
|
2324
Middlesex Water
MSEX
$1.1B
| $1.94M | ﹤0.01% |
52,807
-11,782
| -18% | -$436K |
|
2325
Neurogene
NGNE
$769M
| $1.94M | ﹤0.01% |
6,871
-36
| -0.5% | -$9.94K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.